IMMP - Immutep: Australian Immune-Focused Company Pureplay LAG3 Player June, 12 2022 08:51 AM Immutep Limited Immutep has been developing anti-LAG3 compounds for over a decade. Recent approval of the first such compound from BMY was a watershed event. However, IMMP has a long way to go. For further details see: Immutep: Australian Immune-Focused Company, Pureplay LAG3 Player